Editorji is a popular short video news and information platform based in India. It was founded in 2018 by Vikram Chandra, one of India’s leading journalists, and has risen to prominence in the digital news space in a relatively short span of time. The platform is primarily designed for mobile devices, with applications available for Android and iOS.

ABOUT US:

about us editorji

Latest Video News: Editorji provides the latest news video headlines, latest videos clip from India and the World. Get all breaking news videos on Entertainment, Business, Coronavirus, Elections, Politics and more.

Latest Video News, Breaking News, Bollywood, Political, Sports, Business News | Editorji

+91 11 4035 6666 / info@editorji.com
3rd floor, Plot B, Khasara no 360, Sultanpur, New Delhi, Delhi 110030
<a title="mail to us" href="mailto:info@editorji.com">Send Feedback</a>
<a title="Contact Us" href="mailto:info@editorji.com">Contact Us</a>

REACH US

Contact for any questions, suggestions, comments, feedback or advertisement on Editorji.com, we are always looking forward to hearing from you.

Contact Us for Feedback, Suggestions and Advertising 

Editorji content is better experienced in our app.

Addressing the World Economic Forum in Davos, UN Secretary-General Antonio Guterres warned the world that failure to vaccinate every person against Covid-19 will give rise to new variants of coronavirus.
Guterres stressed pushing the inoculation drive across the world and helping provide countries with jabs that do not have enough vaccines against the deadly virus.
The UN chief further warned that future variants of the virus will bring daily life and economies to a grinding halt.
Also watch | WHO recommends two new Covid-19 treatments. Here are the details
"The last two years have demonstrated a simple but brutal truth – if we leave anyone behind, in the end, we leave everyone behind. If we fail to vaccinate every person, we give rise to new variants that spread across borders and bring daily life and economies to a grinding halt", he said.
Guterres also raised concerns over that the world is ‘nowhere near the targets set by the World Health Organisation (WHO) which had given a call to vaccinate 40 percent of the earth’s population by the end of 2021 and 70 percent by the middle of 2022.
The UN chief urged the pharmaceutical companies around the world to "stand in solidarity with developing countries by sharing licenses, know-how, and technology so we can all find a way out of this pandemic."

Failure to vaccinate everyone against Covid, will give rise to new variants: UN chief

UN chief Antonio Guterres has warned the world that failure to vaccinate every person against Covid-19 will give rise to new variants of coronavirus.

UN Secretary-General Antonio Guterres&nbsp;has warned the world that failure to vaccinate every person against Covid-19 will give rise to new variants of coronavirus.
Addressing the World Economic Forum in Davos,&nbsp;Guterres stressed on pushing the inoculation drive across the world and helping poor countries that do not have enough vaccines against the deadly virus.
The UN chief further warned that future variants of the virus will bring daily life and economies to a grinding halt.
((BYTE))
Guterres also raised concerns over the fact that the world is &lsquo;nowhere near the targets set by the World Health Organisation, which had given a call to vaccinate 40 percent of the earth&rsquo;s population by the end of 2021 and 70 percent by the middle of 2022.

UN chief Antonio Guterre&nbsp;stressed on pushing the inoculation drive across the world and helping poor countries with Covid-19 vaccines

Addressing the World Economic Forum in Davos, UN Secretary-General Antonio Guterres warned the world that failure to vaccinate every person against Covid-19 will give rise to new variants of coronavirus.
Guterres stressed pushing the inoculation drive across the world and helping provide countries with jabs that do not have enough vaccines against the deadly virus.
The UN chief further warned that future variants of the virus will bring daily life and economies to a grinding halt.
Also watch |&nbsp;<a href="https://www.editorji.com/coronavirus/who-recommends-two-new-covid-19-treatments-here-are-the-details-1642135685224" target="_blank">WHO recommends two new Covid-19 treatments. Here are the details</a>
"The last two years have demonstrated a simple but brutal truth &ndash; if we leave anyone behind, in the end, we leave everyone behind. If we fail to vaccinate every person, we give rise to new variants that spread across borders and bring daily life and economies to a grinding halt", he said.
Guterres also raised concerns over the fact that the world is &lsquo;nowhere near the targets set by the World Health Organisation (WHO) which had given a call to vaccinate 40 percent of the earth&rsquo;s population by the end of 2021 and 70 percent by the middle of 2022.
The UN chief urged the pharmaceutical companies around the world to "stand in solidarity with developing countries by sharing licenses, know-how, and technology so we can all find a way out of this pandemic."

The chief of the World Health Organisation on Thursday called on manufacturers of vaccines that already have WHO Emergency Use Listing to prioritise COVAX, not shareholder profit.
WHO Director General Tedros Adhanom Ghebreyesus made the remarks a day after the WHO granted emergency use approval for Bharat Biotech's COVID-19 vaccine Covaxin.
"Yesterday we added another new tool, with the Emergency Use Listing of Covaxin, the 8th vaccine to receive WHO validation for safety, efficacy and quality," he said at a media briefing on COVID-19.
The announcement by the WHO came after the Technical Advisory Group (TAG), an independent advisory committee of the world body recommended Emergency Use Listing(EUL) status for Covaxin, and days after the TAG sought "additional clarifications" from Bharat Biotech on October 26 to conduct a final "risk-benefit assessment" of the vaccine for global use.
Emergency Use Listing contributes to vaccine equity, by enabling countries to expedite their own regulatory approval to import and roll out vaccines, he said.
"We continue to call on manufacturers of vaccines that already have WHO Emergency Use Listing to prioritize COVAX, not shareholder profit," Tedros said.
"We encourage all vaccine manufacturers who have not yet received Emergency Use Listing to contact WHO to discuss how to accelerate the process through rolling submissions," he said.
COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations, and the WHO.

Tedros Adhanom: makers of WHO-approved Covid-19 jabs must prioritise COVAX, not profit

Tedros: Makers of WHO-approved Covid-19 jabs must prioritise COVAX, not profit

The chief of the World Health Organisation has called on manufacturers of vaccines that already have WHO Emergency Use Listing to prioritise COVAX, not shareholder profit.
WHO Director-General Tedros Adhanom Ghebreyesus made the remarks after the WHO granted emergency use approval for Bharat Biotech's Covid-19 vaccine Covaxin.
Emergency Use Listing contributes to vaccine equity, by enabling countries to expedite their own regulatory approval to import and roll out vaccines.
Covid-19 Vaccines Global Access or&nbsp;COVAX&nbsp;is a worldwide initiative aimed at equitable access to Covid-19 vaccines directed by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations, and the WHO.

WHO Director General Tedros Adhanom Ghebreyesus made the remarks a day after the WHO granted emergency use approval for Bharat Biotech's Covid-19 vaccine Covaxin.
&nbsp;

The chief of the World Health Organisation on Thursday called on manufacturers of vaccines that already have WHO Emergency Use Listing to prioritise COVAX, not shareholder profit.
WHO Director General Tedros Adhanom Ghebreyesus made the remarks a day after the WHO granted emergency use approval for Bharat Biotech's Covid-19 vaccine Covaxin.
"Yesterday we added another new tool, with the Emergency Use Listing of Covaxin, the 8th vaccine to receive WHO validation for safety, efficacy and quality," he said at a media briefing on COVID-19.
Also watch |&nbsp;<a href="https://www.editorji.com/india-news/coronavirus-how-do-covid-19-boosters-work-and-are-they-same-as-the-original-vaccines-1636079209378" target="_blank">Coronavirus: How do Covid-19 boosters work and are they same as the original vaccines?</a>
The announcement by the WHO came after the Technical Advisory Group (TAG), an independent advisory committee of the world body recommended Emergency Use Listing(EUL) status for Covaxin, and days after the TAG sought "additional clarifications" from Bharat Biotech on October 26 to conduct a final "risk-benefit assessment" of the vaccine for global use.
Emergency Use Listing contributes to vaccine equity, by enabling countries to expedite their own regulatory approval to import and roll out vaccines, he said.
"We continue to call on manufacturers of vaccines that already have WHO Emergency Use Listing to prioritize COVAX, not shareholder profit," Tedros said.
"We encourage all vaccine manufacturers who have not yet received Emergency Use Listing to contact WHO to discuss how to accelerate the process through rolling submissions," he said.
COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations, and the WHO.

President of the 76th session of the UN General Assembly Abdulla Shahid has said he received the two doses of the Covishield vaccine manufactured in India
He also added that a &ldquo;large portion&rdquo; of other countries around the world have also received India&rsquo;s Covid-19 vaccine, Covishield.
The Covishield vaccine, developed by AstraZeneca, is manufactured in India by Pune-based Serum Institute of India.
Shahid was responding to a question on whether any Covid-19 vaccine should be recognised and considered or only the ones validated by the World Health Organization or any other group.
Shahid said he took Covishield and &lsquo;survived&rsquo; but added that a &lsquo;someone else, a medical person make that call&rsquo; on recognizing vaccine
India has exported over 66 million vaccine doses to nearly 100 countries through grants, commercial shipments and the COVAX facility.

'I got India's Covishield vaccine': UNGA President Abdulla Shahid

President of the 76th session of the UN General Assembly Abdulla Shahid has said he had received the two doses of the Covishield vaccine manufactured in India

//UNGA president Abdulla Shahid: received 2 doses of Covishield&nbsp;&amp; survived
//Shahid: a &ldquo;large portion&rdquo; of other countries also received Covishield
//Covishield,&nbsp;developed by AstraZeneca, is manufactured by Pune-based SII
//Shahid: a medical person should make that call on recognizing vaccine
//India has exported over 66 million Covid vaccine doses to nearly 100 countries
&nbsp;

India has exported over 66 million vaccine doses to nearly 100 countries through grants, commercial shipments and the COVAX facility.

President of the 76th session of the UN General Assembly Abdulla Shahid has said he received the two doses of the Covishield vaccine manufactured in India
He also added that a &ldquo;large portion&rdquo; of other countries around the world have also received India&rsquo;s Covid-19 vaccine, Covishield.
The Covishield vaccine, developed by AstraZeneca, is manufactured in India by Pune-based Serum Institute of India.
Also Read&nbsp;<a href="https://www.editorji.com/india-news/italy-recognises-india-s-covishield-jabbed-travelers-eligible-for-green-pass-1632489132790" target="_blank">Italy recognises India's Covishield, jabbed travelers eligible for green pass</a>
Shahid was responding to a question on whether any Covid-19 vaccine should be recognised and considered or only the ones validated by the World Health Organization or any other group.
Shahid said he took Covishield and &lsquo;survived&rsquo; but added that&nbsp; &lsquo;someone else, a medical person' should make that call&rsquo; on recognizing vaccine
India has exported over 66 million vaccine doses to nearly 100 countries through grants, commercial shipments and the COVAX facility.

The government on Monday said that India will resume the export of Covid-19 vaccines under the Vaccine Maitri initiative in October.
The announcement comes ahead of PM Modi's visit to Washington starting Tuesday where vaccines are likely to be discussed at the Quad summit
Addressing the media, the Union Health Minister Mansukh Mandaviya said that India will resume the export of coronavirus vaccines in order to fulfill its commitment towards COVAX.
The central government had supplied over 66 million doses of Covid-19 vaccines to more than 70 countries as part of the Vaccine Maitri initiative before halting it owing to the sharp surge in cases of infection.&nbsp; External Affairs Minister (EAM) Jaishankar had slammed critics of initiative, labeling them as &lsquo;non-serious, irresponsible&rsquo;
Mandaviya added that more than 30 crore doses of Covid-19 vaccines will be produced in India in the month of October alone and over 100 crore doses will be produced in the fourth quarter of this year
The government wants to vaccinate all of its 94.4 crore adults by December and has so far given at least one dose to 61 per cent of them.

Centre: India to resume export of Covid jabs under Vaccine Maitri in October

The government on Monday said that India will resume the export of Covid-19 vaccines under the Vaccine Maitri initiative in October

//India to resume Covid vaccines export under Vaccine Maitri initiative in October
//Govt's&nbsp;announcement comes ahead of&nbsp;PM Modi's visit to the US
//Covis vaccines likely to be discussed at the Quad summit in Washington
//Mansukh Mandaviya: India&nbsp;to fulfill its commitment towards COVAX
//Govt halted&nbsp;vaccine export it owing to Covid&nbsp;case surge back home
//Mandaviya:&nbsp;over 100 crore doses will be produced in the 4th quarter
//Govt has so far given at least one dose to 61% of the eligible population
&nbsp;

Addressing the media, the Union Health Minister Mansukh Mandaviya said that India will resume the export of coronavirus vaccines in order to fulfill its commitment towards COVAX.

The government on Monday said that India will resume the export of Covid-19 vaccines under the Vaccine Maitri initiative in October.
The announcement comes ahead of PM Modi's visit to Washington starting Tuesday where vaccines are likely to be discussed at the Quad summit
Addressing the media, the Union Health Minister Mansukh Mandaviya said that India will resume the export of coronavirus vaccines in order to fulfill its commitment towards COVAX.
The government had supplied over 66 million doses of Covid-19 vaccines to more than 70 countries as part of the Vaccine Maitri initiative before halting it owing to the sharp surge in cases of infection back home.&nbsp; External Affairs Minister (EAM) Jaishankar had slammed critics of initiative, labeling them as &lsquo;non-serious, irresponsible&rsquo;
Mandaviya added that more than 30 crore doses of Covid-19 vaccines will be produced in India in the month of October alone and over 100 crore doses will be produced in the fourth quarter of this year
The government wants to vaccinate all of its 94.4 crore adults by December and has so far given at least one dose to 61 per cent of them.

The White House on Monday reassured that the Joe Biden administration is eager to continue its partnership in assisting India in the form of Covid-19&nbsp;vaccines. Speaking about the delay in vaccine grants to India, Jen Psaki&nbsp;pointed out the legal and regulatory&nbsp;issues and clarified that the hold-up is not on the&nbsp;USA's end.While the US has shipped over 110 million vaccines to middle and low-income countries, India has only received&nbsp;7.5 million doses. This is due to the unresolved liability issues between the Indian government and vaccine manufacturers.&nbsp;Meanwhile, Indian American Congressman Raja&nbsp;Krishnamoorthi on Friday said that 7.5 million doses were not enough and urged the Biden&nbsp;administration to do more.&nbsp;

Delay in vaccine grants to India not a hold-up on USA's side: White House

The White House on Monday reassured that the Joe Biden administration is eager to continue its partnership in assisting India in the form of Covid-19&nbsp;vaccines.

White House: US eager to continue assisting India in form of&nbsp;vaccines Delay in vaccine grants to India not a hold-up on USA's side: White House White House: legal and regulatory issues need to be worked out US has shipped over 110 mn vaccines to middle and low income countries
India has been allocated only 7.5 mn vaccines due to&nbsp;liability issues

The White House on Monday reassured that the Joe Biden administration is eager to continue its partnership in assisting India in the form of Covid-19&nbsp;vaccines.

The White House on Monday reassured that the Joe Biden administration is eager to continue its partnership in assisting India to combat the Covid-19 pandemic Speaking about the delay in vaccine grants to India, White&nbsp;House Spokesperson Jen Psaki&nbsp;said that the hold-up is not on the&nbsp;USA's end. She added that there are legal and regulatory issues that need to be worked.&nbsp;
Also watch:&nbsp;<a href="https://www.editorji.com/story/who-flags-global-vaccine-inequality-says-stop-booster-shots-for-delta-variant-1628130612488">WHO flags global vaccine inequality, says stop booster shots for Delta variant</a> While the US has shipped over 110 million vaccines to middle and low-income countries, India has been only allocated&nbsp;7.5 million doses due to unresolved liability issues between the Indian government and vaccine manufacturers.&nbsp;

Dr Poonam Khetrapal Singh, regional director of the World Health Organisation, South-East Asia, on Monday said that India has been offered 7.5 million doses of Moderna vaccine through the global health body&rsquo;s Covid-19 Vaccines Global Access (COVAX) programme.
However, there is no clarity so far when the jabs would be available in the country as WHO said that the availability is &ldquo;subject to clearance of indemnity clause.&rdquo;Last month, the Drugs Controller General of India had granted restricted emergency use authorisation to Moderna for its Covid-19 vaccine. The doses are to be imported by drug manufacturer Cipla, but will be under the purview of the govt.
Reports say, the Indian government has put forth certain conditions for finalising the indemnity clause contract and has sent it to the US drug manufacturer for their perusal.

WHO: India to get 7.5 million doses of Moderna jab via COVAX

WHO says India has been offered 7.5 million doses of Moderna jab via COVAX, but availability subject to finalising indemnity clause for import

WHO: India has been offered 7.5 million doses of Moderna vaccine via COVAX
No clarity on when the Moderna jabs would be available in India, says WHO
WHO: availability of Moderna&nbsp;vaccine subject to clearance of indemnity clause
Last month, the DCGI&nbsp;granted restricted emergency use authorisation to Moderna
Moderna&nbsp;vaccine&nbsp;to be imported by Cipla, but will be under govt purview&nbsp;
Reports: Govt&nbsp;finalising indemnity clause contract, sent it to US FDA&nbsp;

India has been offered 7.5 million doses of Moderna vaccine through WHO&rsquo;s COVAX programme. The availability of doses is subject to clearance of indemnity clause.

Dr Poonam Khetrapal Singh, regional director of the World Health Organisation, South-East Asia, on Monday said that India has been offered 7.5 million doses of Moderna vaccine through the global health body&rsquo;s Covid-19 Vaccines Global Access (COVAX) programme.
However, there is no clarity so far when the jabs would be available in the country as WHO said that the availability is &ldquo;subject to clearance of <a title="indemnity clause.&rdquo;" href="https://www.editorji.com/story/indemnity-what-is-it-what-do-pharma-majors-like-pfizer-moderna-sii-want-it-1622754907349">indemnity clause.&rdquo;</a>
Also watch:&nbsp;<a href="https://www.editorji.com/story/what-is-covid-19-r-factor-1626328730182">In Depth: What is Covid-19 'R' Factor?</a>
Last month, the Drugs Controller General of India had granted restricted emergency use authorisation to Moderna for its Covid-19 vaccine. The doses are to be imported by drug manufacturer Cipla&nbsp;but will be under the purview of the govt.
Reports say the Indian government has put forth certain conditions for finalising the indemnity clause contract and has sent it to the US drug manufacturer for their perusal.

The United States on Monday announced its plans to allocate 55 million doses of Covid-19 vaccines to the rest of the world, including 16 million to Asian nations such as India and Bangladesh.
With the previous allocation of 25 million, the Joe&nbsp;Biden&nbsp;administration has so far announced to distribute 80 million doses of America&rsquo;s own vaccine supply which the US President had pledged to allocate by the end of June in service of ending the pandemic globally.
Earlier this month, the administration announced the plan for the first 25 million doses that the US has already begun shipping.
For these 80 million doses, the US will share 75 per cent through COVAX and 25 per cent will be targeted to help deal with surges around the world.

US announces plans to allocate 55 million Covid-19 vaccine doses to be shared globally

//US to give away 55 million does of Covid-19 vaccine globally&nbsp; //16 million doses allocated to Asian nations&nbsp;including&nbsp;India&nbsp; //Biden admin has pledged to distribute 80 million doses from US's own supply //America has already begun shipping the 25 million vaccines&nbsp; //US will share 75% through COVAX&nbsp;&amp; 25% will target surges around the globe&nbsp;

The United States on Monday announced its plans to allocate 55 million doses of Covid-19 vaccines to the rest of the world, including 16 million to Asian nations such as India and Bangladesh.
With the previous allocation of 25 million, the Joe&nbsp;Biden&nbsp;administration has so far announced to distribute 80 million doses of America&rsquo;s own vaccine supply which the US President had pledged to allocate by the end of June in service of ending the pandemic globally.
Earlier this month, the administration announced the plan for the first 25 million doses that the US has already begun shipping.
For these 80 million doses, the US will share 75 per cent through COVAX and 25 per cent will be targeted to help deal with surges around the world.

Countries belonging to the G7 and the European Union can afford to donate more than 150 million vaccine doses to countries in need without compromising their vaccination commitments, UNICEF said on Monday.
A study by British firm Airfinity showed that the world's seven richest states and the EU could help close the world's vaccine gap by sharing just 20 per cent of their June, July and August stocks with the Covax jab scheme for poorer nations.
Adding to this UNICEF director Henrietta Fore said that the rich countries could do this while still fulfilling their vaccination commitments to their own populations.
The UK is due to host its fellow G7 member states Canada, France, Germany, Italy, Japan and the US for a summit in June.

Rich countries can afford to donate Covax jabs, says UNICEF

Countries belonging to the G7 and the European Union can afford to donate more than 150 million vaccine doses to countries in need without compromising their vaccination commitments, UNICEF said on Monday.
 A study by British firm Airfinity showed that the world's seven richest states and the EU could help close the world's vaccine gap by sharing just 20 per cent of their June, July and August stocks with the Covax jab scheme for poorer nations.
 Adding to this UNICEF director Henrietta Fore said that the rich countries could do this while still fulfilling their vaccination commitments to their own populations.
 The UK is due to host its fellow G7 member states Canada, France, Germany, Italy, Japan and the US for a summit in June.

Countries belonging to the G7 and the European Union can afford to donate more than 150 million vaccine doses to countries in need without compromising their vaccination commitments, UNICEF said on Monday.
A study by British firm Airfinity showed that the world's seven richest states and the EU could help close the world's vaccine gap by sharing just 20 per cent of their June, July and August stocks.
Adding to this UNICEF director Henrietta Fore said that the rich countries could do this while still fulfilling their vaccination commitments to their own populations.
&nbsp;

US President Joe Biden will use his first big presidential moment on the global stage at Friday's Group of Seven meeting of world leaders to announce a big US aid to supply Covid vaccine to the poor countries. Biden will announce that the US will soon begin releasing $4 billion for an international effort to bolster the purchase and distribution of coronavirus vaccine to poor nations, White House officials said. Biden will also encourage G-7 partners to make good on their pledges to COVAX, a WHO initiative to improve access to vaccines, news agency AP has reported. Former President Donald Trump declined to participate in the COVAX initiative because of its ties to WHO that Trump accused of covering up China's missteps in handling the virus .

Joe Biden rolling out plan for $4 billion global Covid-19 vaccine effort

Biden is set to announce a $4 billion US aid&nbsp;for an international effort to bolster the purchase and distribution of coronavirus vaccine to poor nations

Biden rolling out plan for $4 billion global Covid vaccine effort

US President Joe Biden will use his first big presidential moment on the global stage at Friday's Group of Seven meeting of world leaders to announce a big US aid to supply Covid vaccine to the poor countries. Biden will announce that the US will soon begin releasing $4 billion for an international effort to bolster the purchase and distribution of coronavirus vaccine to poor nations, White House officials said. Biden will also encourage G-7 partners to make good on their pledges to COVAX, a WHO initiative to improve access to vaccines, news agency AP has reported.

US President Joe Biden will use his first big presidential moment on the global stage at Friday's Group of Seven meeting of world leaders to announce a big US aid to supply Covid vaccine to the poor countries. Biden will announce that the US will soon begin releasing $4 billion for an international effort to bolster the purchase and distribution of coronavirus vaccine to poor nations, White House officials said. Biden will also encourage G-7 partners to make good on their pledges to COVAX, a WHO initiative to improve access to vaccines, news agency AP has reported. Former President Donald Trump declined to participate in the COVAX initiative because of its ties to WHO that Trump accused of covering up China's missteps in handling the virus .

Covid-19: UK PM called world leaders to fight common foe

After PM Modi, the United Kingdom&rsquo;s Prime Minister Boris Johnson too addressed the pandemic concerns in his UNGA speech on Saturday. Saying that the coronavirus pandemic has frayed the bonds between nations, he called the world leaders to unite against the common foe. Johnson set out a plan to prevent another global pandemic, including a network of zoonotic research labs around the world to identify dangerous pathogens. Johnson committed 500 million pounds through the global COVAX vaccine-procurement pool to help 92 of the world's poorest countries obtain a coronavirus vaccine, should one become available.

UK PM at UNGA:&nbsp;frayed the bonds between nations
UK PM Johnson: Covis is a common foe
Johnson set out a plan to prevent another pandemic
Johnson committed 500 million pounds&nbsp;

After PM Modi, the United Kingdom&rsquo;s Prime Minister Boris Johnson too addressed the pandemic concerns in his UNGA speech on Saturday. Saying that the coronavirus pandemic has frayed the bonds between nations, he called the world leaders to unite against the common foe. Johnson set out a plan to prevent another global pandemic, including a network of zoonotic research labs around the world to identify dangerous pathogens. Johnson committed 500 million pounds through the global COVAX vaccine-procurement pool to help 92 of the world's poorest countries obtain a coronavirus vaccine, should one become available.

WHO tells India to join global 'Covax' plan

The World Health Organisation is in talks with India about joining the 'COVAX' global vaccine allocation plan. A senior WHO adviser said on Monday, that India is eligible, like all countries in the world, to be part of the COVAX facility and discussions are ongoing. WHO added that India has extensive experience with vaccines. 
The WHO and the GAVI vaccine alliance are leading the COVAX facility, aimed at helping buy and distribute vaccines against the novel coronavirus fairly around the world.
United States meanwhile has secured their own supplies through bilateral deals and have said they will not join COVAX.

Talks on with India to join global Covax&nbsp;allocation: WHO
WHO: India has extensive experience with vaccines
WHO and GAVI&nbsp;leading global Covid-19 vaccine facility
Move to help buy and distribute vaccines fairly globally
US secured supply through bilateral deals, won't join Covax

The World Health Organisation is in talks with India about joining the 'COVAX' global vaccine allocation plan. A senior WHO adviser said on Monday, that India is eligible, like all countries in the world, to be part of the COVAX facility and discussions are ongoing. WHO added that India has extensive experience with vaccines. 
The WHO and the GAVI vaccine alliance are leading the COVAX facility, aimed at helping buy and distribute vaccines against the novel coronavirus fairly around the world.
United States meanwhile has secured their own supplies through bilateral deals and have said they will not join COVAX.

US won't join global effort on Covid vaccine

The Trump administration has said that it will not join the global effort to develop and distribute a Covid-19 vaccine, says don't want to be constrained by WHO

The Trump administration has said that it will not join the global effort to develop and distribute a Covid-19 vaccine, news agency Associated Press has reported. The Trump administration has said that it does not want to be constrained by multilateral groups like the World Health Organization. The decision to go it alone follows the US decision in July to pull out of the WHO. Some nations have worked directly to secure supplies of vaccine, but others are pooling efforts to ensure success against the contagion. More than 150 countries are setting up the Covid-19 Vaccines Global Access Facility, or COVAX.

covax

Categories